CRIS Current Research Information System

MUSIANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.434
AS - Asia 6.125
EU - Europa 4.996
AF - Africa 340
Continente sconosciuto - Info sul continente non disponibili 310
SA - Sud America 257
OC - Oceania 3
Totale 18.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.357
CN - Cina 1.848
VN - Vietnam 1.644
SG - Singapore 1.476
GB - Regno Unito 1.369
DE - Germania 635
IT - Italia 632
UA - Ucraina 572
SE - Svezia 553
HK - Hong Kong 353
IN - India 337
FR - Francia 333
RU - Federazione Russa 302
BR - Brasile 186
IE - Irlanda 177
JP - Giappone 129
KR - Corea 104
ZA - Sudafrica 103
EE - Estonia 93
CH - Svizzera 81
TG - Togo 78
SC - Seychelles 54
CI - Costa d'Avorio 52
FI - Finlandia 49
CA - Canada 47
NL - Olanda 46
BG - Bulgaria 41
BE - Belgio 35
IR - Iran 30
NG - Nigeria 30
AR - Argentina 29
BD - Bangladesh 27
TH - Thailandia 19
GR - Grecia 18
IQ - Iraq 18
PH - Filippine 18
JO - Giordania 17
AT - Austria 16
ID - Indonesia 15
RO - Romania 13
TR - Turchia 13
UZ - Uzbekistan 13
TW - Taiwan 12
PK - Pakistan 11
SA - Arabia Saudita 11
MX - Messico 10
EC - Ecuador 8
LB - Libano 8
PL - Polonia 8
CL - Cile 7
CO - Colombia 7
EG - Egitto 6
PY - Paraguay 6
AZ - Azerbaigian 5
ES - Italia 5
UY - Uruguay 5
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
MY - Malesia 4
PR - Porto Rico 4
TN - Tunisia 4
VE - Venezuela 4
DZ - Algeria 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AU - Australia 2
BO - Bolivia 2
ET - Etiopia 2
KZ - Kazakistan 2
OM - Oman 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HU - Ungheria 1
KE - Kenya 1
KH - Cambogia 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
SV - El Salvador 1
Totale 18.158
Salva come PNG Salva come JPEG
Città #
Southend 1.162
Singapore 938
Ashburn 596
Chandler 541
Dong Ket 501
Fairfield 455
Jacksonville 431
San Jose 357
Hong Kong 334
Hefei 317
Ho Chi Minh City 280
Wilmington 260
Princeton 246
Ann Arbor 237
Woodbridge 236
Seattle 230
Hanoi 221
Houston 218
Beijing 196
Boardman 194
Dublin 174
Cambridge 160
Santa Clara 156
Tokyo 125
Westminster 119
Padova 118
Lauterbourg 113
Nanjing 108
Los Angeles 95
Berlin 94
Council Bluffs 90
Seoul 87
New York 83
Milan 80
Medford 79
Lomé 78
Buffalo 76
Bern 74
Mülheim 69
Saint Petersburg 66
Shenyang 55
Abidjan 52
Jinan 52
Mahé 52
Helsinki 46
Changsha 44
Dallas 44
Haiphong 44
Shanghai 44
Sofia 41
Redwood City 40
Tianjin 38
Bengaluru 37
Bologna 37
Guangzhou 37
Nanchang 37
Brussels 35
Zhengzhou 33
Abeokuta 30
Da Nang 29
Hangzhou 29
Florence 28
Hebei 28
Verona 26
Bremen 24
Jiaxing 24
Phoenix 24
Des Moines 21
Olalla 20
San Diego 20
Rome 19
Taizhou 19
Toronto 19
Paris 18
Amman 17
Dearborn 17
Norwalk 16
Shenzhen 16
Frankfurt am Main 15
San Francisco 15
The Dalles 15
Chicago 14
Kunming 14
London 14
Ningbo 14
Redondo Beach 14
Wuhan 14
Brooklyn 13
San Venanzo 13
São Paulo 13
Turin 13
Yubileyny 13
Haikou 12
Hyderabad 12
Taiyuan 12
Falls Church 11
Kuban 11
Pune 11
Rio de Janeiro 11
Thái Nguyên 11
Totale 11.491
Salva come PNG Salva come JPEG
Nome #
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 253
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 244
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 229
Bio-chemiluminescent miniaturized biosensors 218
Bio- and chemiluminescence imaging in analytical chemistry 217
A miniaturized multiplexed analytical device with chemiluminescence "contact" imaging detection for diagnostic applications 206
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 206
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 202
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 202
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 201
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 200
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 196
Analysis of HPV16 E6*I-II transcripts in cervical samples 194
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 193
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 192
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 192
A proteomic approach to the analysis of B19 capsid proteins 189
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 188
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 187
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 187
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 186
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 183
Analisi della competenza funzionale di cloni genomici di parvovirus B19 182
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 182
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 181
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 181
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 180
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 178
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 175
Recurrent erythema in patients with long-term parvovirus B19 infection 175
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 175
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 174
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 170
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 169
Parvovirus B19-derived fetal complications following gestational infection. 167
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 166
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 166
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 166
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 165
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 163
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 163
Analysis of the functional competence of genomic clones of Parvovirus B19 163
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 162
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 161
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 160
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 160
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 159
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 158
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 157
No correlation between cytomegalovirus and alopecia areata [2] 157
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 156
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 155
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 155
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 154
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 153
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 153
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 152
Diagnosi virologica di infezione da papillomavirus umani 151
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 151
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 151
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 151
Evidence of human bocavirus viremia in healthy blood donors. 151
Molecular luminescence imaging 149
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 149
Development of a miniaturized analytical device employing luminescence “contact” imaging detection for parvovirus B19 infection diagnosis 148
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 148
Human papillomavirus in melanoma: reply from authors 146
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 145
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 144
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 144
Catalytic partial oxidation of CH4-H2mixtures over Ni foams modified with Rh and Pt 143
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 142
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 142
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 142
Implicazioni nella progressione della patologia cervicale 140
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 138
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 135
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 134
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 133
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 133
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 132
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 132
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 131
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 130
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 129
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 129
Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia 129
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 128
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 127
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 126
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 126
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 125
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 124
Detection of parvovirus B19 IgG: choice of antigens and serological tests 122
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 121
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 118
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 116
Luminescence detection in point-of-care testing devices 115
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 115
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 114
Totale 16.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.966 0 110 140 224 179 116 22 116 67 226 354 412
2022/20232.297 247 339 126 272 177 139 57 137 358 45 236 164
2023/2024798 42 94 39 128 44 165 108 63 18 33 21 43
2024/20252.057 80 359 221 144 304 112 225 45 17 53 60 437
2025/20264.968 350 712 536 427 605 303 360 116 886 348 178 147
2026/2027143 84 59 0 0 0 0 0 0 0 0 0 0
Totale 18.465